About Particle Therapeutics Limited
Particle Therapeutics, a spin out company of the University of Oxford, is a privately-held, UK-based company dedicated to the development, testing and commercialization of needle-free injection of glucagon in the diabetic patient with severe hypoglycemia. Other applications of Particle Therapeutics' technology may include the delivery of insulin in a selected group of patients with diabetes and other conditions. For more information on Particle Therapeutics go to http://www.particletherapeutics.com
Anesiva Forward Looking Statements
This press release includes "forward-looking statements" within the
meaning of the safe harbor provisions of the United States Private
Securities Litigation Reform Act of 1995. Words such as "expect,"
"estimate," "project," "budget," "forecast," "anticipate," "intend,"
"plan," "may," "will," "could," "should," "believes," "predicts,"
"potential," "continue," and similar expressions are intended to identify
such forward-looking statements. Forward-looking statements in this press
release include matters that involve known and unknown risks, uncertainties
and other factors that may cause actual results, levels of activity,
performance or achievements to differ materially from results expressed or
implied by this press release. Such risk factors include, among others: the
timing and results of our clinical trials, whether Anesiva will succeed in
licensing its needle-free drug technology technology for other uses;
whether Anesiva can commercially release new products successfully and the
|SOURCE Anesiva, Inc.|
Copyright©2007 PR Newswire.
All rights reserved